Cargando…
Feto-Maternal Effects of Adding Rifampicin to Ursodeoxycholic Acid in the Treatment of Intrahepatic Cholestasis of Pregnancy
Background Various pharmacological agents are used to manage intrahepatic cholestasis of pregnancy (ICP) for maternal pruritus and to lower serum bile acids in fear of adverse fetal outcomes. Ursodeoxycholic acid (UDCA) is the most widely used drug, but some patients do not respond to it. Neither UD...
Autores principales: | Kumari, Anjali, Kumar, Avinash, Kumar, Manoj, Swati, Swati |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9840412/ https://www.ncbi.nlm.nih.gov/pubmed/36654556 http://dx.doi.org/10.7759/cureus.32509 |
Ejemplares similares
-
Maternal and Perinatal Outcome in Pregnancy Complicated by Intrahepatic Cholestasis
por: Jhirwal, Manisha, et al.
Publicado: (2022) -
The Reversed Feto-Maternal Bile Acid Gradient in Intrahepatic Cholestasis of Pregnancy Is Corrected by Ursodeoxycholic Acid
por: Geenes, Victoria, et al.
Publicado: (2014) -
Effects of Intrahepatic Cholestasis on the Foetus During Pregnancy
por: Sahni, Anushree, et al.
Publicado: (2022) -
Association Between Complete Blood Count Components and Intrahepatic Cholestasis of Pregnancy
por: Silva, Jessica, et al.
Publicado: (2020) -
Never Too Soon: An Unusual Case of Intrahepatic Cholestasis of Pregnancy at Five Weeks Gestation
por: Wongjarupong, Nicha, et al.
Publicado: (2020)